Thomas C Condamine

Title: **The Innovations of Thomas C. Condamine**

Introduction

Thomas C. Condamine is a notable inventor based in Philadelphia, PA, whose work has significantly contributed to the field of cancer research. With one active patent to his name, Condamine focuses on the isolation and monitoring of specific immune cells that play a role in cancer progression.

Latest Patents

Thomas C. Condamine's patent, titled “Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells,” introduces a groundbreaking method for obtaining a population of cells enriched with human polymorphonuclear myeloid derived suppressor cells (PMN-MDSCs). This method involves isolating cells that express the LOX-1 receptor, which is crucial for determining the effectiveness of treatments and tracking cancer metastasis. The patent describes various cell isolation and diagnostic approaches that can enhance cancer care.

Career Highlights

Condamine is affiliated with The Wistar Institute of Anatomy and Biology, a prominent research institution known for its dedication to advancing biomedical science. His research focuses on the intricate relationships between the immune system and cancer, offering insights that may lead to innovative therapeutic strategies.

Collaborations

One of his notable collaborators is Dmitry Gabrilovich, with whom Condamine works closely at The Wistar Institute. Together, they explore the mechanisms by which immune cells can be utilized to improve cancer treatment outcomes, showcasing the power of collaboration in scientific research.

Conclusion

Thomas C. Condamine stands out as an influential figure in the realm of cancer research, with his innovative patent laying the foundation for future studies and potential therapeutic applications. His contributions, alongside collaborations with esteemed researchers, signify the ongoing evolution of scientific knowledge in addressing complex health challenges.